Innoviva, Inc. (INVA)
NASDAQ·Healthcare·Biotechnology
$22.60
-0.04%
Mkt Cap $1.68B
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (9 analysts)
$40.00
Range $32.00 – $46.00
Implied Upside
+77.0%
Consensus $40.00 vs current $22.60
NASDAQ·Healthcare·Biotechnology
$22.60
-0.04%
Mkt Cap $1.68B
Buy
4
Hold
0
Sell
0
Price Target (9 analysts)
$40.00
Range $32.00 – $46.00
+77.0%
Consensus $40.00 vs current $22.60